TERAPIA CELULAR, CÉLULAS MADRE Y TEJIDOS
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (8)
2023
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals
Hepatology, Vol. 75, Núm. 3, pp. 550-566
2021
-
The race of CAR therapies: CAR-NK cells for fighting B-cell hematological cancers
Cancers, Vol. 13, Núm. 21
2020
-
Generation, establishment and characterization of a pluripotent stem cell line (CVTTHi001-A) from primary fibroblasts isolated from a patient with activated PI3 kinase delta syndrome (APDS2)
Stem Cell Research, Vol. 49
-
Purification, Culture, and CD19-CAR Lentiviral Transduction of Adult and Umbilical Cord Blood NK Cells
Current Protocols in Immunology, Vol. 131, Núm. 1
2019
-
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
Scientific Reports, Vol. 9, Núm. 1
2018
-
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Journal of Clinical Investigation, Vol. 128, Núm. 9, pp. 3887-3905
2017
-
Pluripotent stem cells and skeletal muscle differentiation: Challenges and immediate applications
The Plasticity of Skeletal Muscle: From Molecular Mechanism to Clinical Applications (Springer Singapore), pp. 1-35